SDGR Reaffirms FY/ Q2 2026 Guidance, Announces Chief Commercial Officer Departure, Names Paul Davie Interim Replacement
Schrodinger, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.80
+7.4% in 1d after detection
Post-detection moves
1h
—
1d
+7.4%
3d
+6.7%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS